Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005-2014
Abstract Introduction The aim of this study is to describe the disease burden and costs of herpes zoster (HZ) in the general adult Japanese population or patients with immunocompromised (IC) conditions or chronic disorders. Methods A retrospective cohort study of individuals aged 18-74 years was con...
Saved in:
Main Authors: | Shinichi Imafuku (Author), Taizo Matsuki (Author), Akiko Mizukami (Author), Yasushi Goto (Author), Sabrina de Souza (Author), Céline Jégou (Author), Veronique Bianco (Author), Dominique Rosillon (Author), Chie Ito (Author), Desmond Curran (Author), Katsiaryna Holl (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
by: Desmond Curran, et al.
Published: (2023) -
Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies
by: Agnes Mwakingwe-Omari, et al.
Published: (2023) -
Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
by: Nikolaos Giannelos, et al.
Published: (2023) -
Atypical presentation of bullous herpes zoster and necrotizing fasciitis in immunocompromised patients
by: Fatimah Al Muqarrab, et al.
Published: (2022) -
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
by: Makoto Shiragami, et al.
Published: (2019)